Development of SARS-COV therapeutics using quaternary protein mimetics
SARS-CoV, a novel virus belonging to group IV coronavirus, was discovered in association with cases of severe acute respiratory syndrome (SARS) in 2003. The spike (S) protein of SARS-CoV is responsible for receptor binding and membrane fusion. The MPER, the Trp-rich membrane proximal external region...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/41875 |